Switzerland has signed an agreement with Moderna to secure early access to the COVID-19 vaccine the US biotech company is developing, the government said on Friday.
Switzerland will get 4.5 million doses of the vaccine.
The quantity will be enough to vaccinate 2.25 million people if as expected two doses are needed per patient.
The government is also talking to other vaccine companies.
According to Reuters, the country has allocated up to 300 million Swiss francs ($329 million) to the project.